With a lot of arguments going around the use of the antimalarial drug hydroxychloroquine against COVID-19, here’s a study trying to uncover the real truth.
The paper written by the authors, a lead investigator from Harvard, Mandeep R Mehra, and Brigham, Massachusetts through retracted their paper from the journal Lancet, triggered a lot of arguments, to an extent of compelling World Heath Oragnizsatiin to temporarily suspend the anti-malarial drug.
Currently, after an internal audit, the trails for hydroxychloroquine has been resumed. Soon after this paper, a second paper was released using the same data set and was published in the New England Journal of Medicine, which was also withdrawn.
After the publication of both papers, so a lot of controversies went about raising the questions regarding the veracity of the data and analysis. The scientists conducting the experiment could not make many breakthroughs due to the legal complications, as the investigation was not given the required access to documents.
The authors stated that their intention was always to perform the required research according to the highest ethical and professional standards. The collaboration was meant to promote good faith at a time of great need during the current COVID-19 pandemic.
“On June 4, three authors of the paper, “Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis”, retracted their study. They were unable to complete an independent audit of the data underpinning their analysis. As a result, they have concluded that they can no longer vouch for the veracity of the primary data sources,” the journal said in a statement.
To know more about origin, virology of COVID-19, Click here
To know more about emerging themes in COVID-19, Click here
To know more about how WhiteCoats can help you in your professional advancement, visit www.whitecoats.com
Want to set up an online consultation for your practice, Click here